Matrix-Bio, Inc., a leader in the field of cancer diagnostics using metabolite profiling, is a featured startup company at the 8th annual New England Venture Summit on December 11 at the Hilton Boston Dedham. Matrix-Bio is seeking investment for its colon cancer-monitoring test, which uses the company’s VeraMarker™ metabolite profiling technology platform to detect the recurrence of cancer months and even years earlier than current diagnostics tests.
Help employers find you! Check out all the jobs and post your resume.
